The U.S. Food and Drug Administration (FDA) has provided an update on its work to prevent Cronobacter sakazakii illnesses associated with consumption of powdered infant formula. FDA published a draft outline of its prevention strategy in November 2022, following the prolific February 2022 recall of Abbott Nutrition powdered infant formula contaminated with C. sakazakii.
FDA engagements with the infant formula industry and other stakeholders showed support for the draft outline, and therefore the strategy will continue without any additions. FDA may add actions to the strategy over time, as appropriate.